| 1 |
Teijin Limited et al v. Ranbaxy Pharmaceuticals Inc. et al |
1:14-cv-00117 |
D.Del. |
|
|
|
|
| 2 |
Teijin Limited et al v. Ranbaxy Pharmaceuticals Inc. et al |
1:14-cv-00117 |
D.Del. |
|
|
|
|
| 3 |
Teijin Limited et al v. Ranbaxy Pharmaceuticals Inc. et al |
1:14-cv-00117 |
D.Del. |
|
|
|
|
| 4 |
Purdue Pharma L.P. et al v. Ranbaxy Inc. et al |
1:11-cv-07104 |
S.D.N.Y. |
|
|
|
|
| 5 |
Purdue Pharma L.P. et al v. Ranbaxy Inc. et al |
1:11-cv-07104 |
S.D.N.Y. |
|
|
|
|
| 6 |
Purdue Pharma L.P. et al v. Ranbaxy Inc. et al |
1:11-cv-07104 |
S.D.N.Y. |
|
|
|
|
| 7 |
Lupin Atlantis Holdings SA v. Ranbaxy Laboratories Limited et al |
1:10-cv-00659 |
D.Del. |
|
|
|
|
| 8 |
ASTRAZENECA AB et al v. RANBAXY PHARMACEUTICALS, INC. et al |
3:05-cv-05553 |
D.N.J. |
|
|
|
|
| 9 |
ASTRAZENECA AB et al v. RANBAXY PHARMACEUTICALS, INC. et al |
3:05-cv-05553 |
D.N.J. |
|
|
|
|
| 10 |
ASTRAZENECA AB et al v. RANBAXY PHARMACEUTICALS, INC. et al |
3:05-cv-05553 |
D.N.J. |
|
|
|
|
| 11 |
ASTRAZENECA AB et al v. RANBAXY PHARMACEUTICALS, INC. et al |
3:05-cv-05553 |
D.N.J. |
|
|
|
|
| 12 |
ASTRAZENECA AB et al v. RANBAXY PHARMACEUTICALS, INC. et al |
3:05-cv-05553 |
D.N.J. |
|
|
|
|
| 13 |
ASTRAZENECA AB et al v. RANBAXY PHARMACEUTICALS, INC. et al |
3:05-cv-05553 |
D.N.J. |
|
|
|
|
| 14 |
ASTELLAS PHARMA, INC. et al v. RANBAXY, INC. et al |
3:05-cv-02563 |
D.N.J. |
|
|
|
|
| 15 |
ASTELLAS PHARMA, INC. et al v. RANBAXY, INC. et al |
3:05-cv-02563 |
D.N.J. |
|
|
|
|
| 16 |
In Re: Rivastigmine Patent Litigation |
1:05-md-01661 |
S.D.N.Y. |
|
- 8 Product company
- 13 Corporate-inventor-started company
|
|
|
| 17 |
In Re: Rivastigmine Patent Litigation |
1:05-md-01661 |
S.D.N.Y. |
|
- 8 Product company
- 13 Corporate-inventor-started company
|
|
|
| 18 |
In Re: Rivastigmine Patent Litigation |
1:05-md-01661 |
S.D.N.Y. |
|
- 8 Product company
- 13 Corporate-inventor-started company
|
|
|
| 19 |
In Re: Rivastigmine Patent Litigation |
1:05-md-01661 |
S.D.N.Y. |
|
- 8 Product company
- 13 Corporate-inventor-started company
|
|
|
| 20 |
In Re: Rivastigmine Patent Litigation |
1:05-md-01661 |
S.D.N.Y. |
|
- 8 Product company
- 13 Corporate-inventor-started company
|
|
|
| 21 |
Ranbaxy Lab Ltd, et al v. Abbott Laboratories |
1:04-cv-08078 |
N.D.Ill. |
|
|
|
|
| 22 |
AVENTIS PHARMACEUTICALS INC. et al v. BARR LABORATORIES, INC. |
2:04-cv-01064 |
D.N.J. |
|
|
|
|
| 23 |
AVENTIS PHARMACEUTICALS INC. et al v. BARR LABORATORIES, INC. |
2:04-cv-01064 |
D.N.J. |
|
|
|
|
| 24 |
AVENTIS PHARMACEUTICALS INC. et al v. IMPAX LABORATORIES, INC. |
2:04-cv-01076 |
D.N.J. |
|
|
|
|
| 25 |
AVENTIS PHARMACEUTICALS INC. et al v. IMPAX LABORATORIES, INC. |
2:04-cv-01076 |
D.N.J. |
|
|
|
|
| 26 |
TAKEDA CHEMICAL, et al v. RANBAXY LABORATORIES, et al |
3:03-cv-05055 |
D.N.J. |
|
|
|
|
| 27 |
TAKEDA CHEMICAL, et al v. RANBAXY LABORATORIES, et al |
3:03-cv-05055 |
D.N.J. |
|
|
|
|
| 28 |
PFIZER INC., et al v. RANBAXY LABORATORIES, et al |
3:03-cv-00792 |
D.N.J. |
|
|
|
|
| 29 |
Pfizer Inc., et al v. Ranbaxy Laboratories, et al |
1:03-cv-00209 |
D.Del. |
|
|
|
|
| 30 |
PFIZER INC., et al v. RANBAXY LABORATORIES, et al |
3:03-cv-00792 |
D.N.J. |
|
|
|
|
| 31 |
PFIZER INC., et al v. RANBAXY LABORATORIES, et al |
3:03-cv-00792 |
D.N.J. |
|
|
|
|
| 32 |
PFIZER INC., et al v. RANBAXY LABORATORIES, et al |
3:03-cv-00792 |
D.N.J. |
|
|
|
|
| 33 |
PFIZER INC., et al v. RANBAXY LABORATORIES, et al |
3:03-cv-00792 |
D.N.J. |
|
|
|
|
| 34 |
Pfizer Inc., et al v. Ranbaxy Laboratories, et al |
1:03-cv-00209 |
D.Del. |
|
|
|
|
| 35 |
Pfizer Inc., et al v. Ranbaxy Laboratories, et al |
1:03-cv-00209 |
D.Del. |
|
|
|
|
| 36 |
Pfizer Inc., et al v. Ranbaxy Laboratories, et al |
1:03-cv-00209 |
D.Del. |
|
|
|
|
| 37 |
Pfizer Inc., et al v. Ranbaxy Laboratories, et al |
1:03-cv-00209 |
D.Del. |
|
|
|
|
| 38 |
SCHERING CORPORATION v. RANBAXY LABORATORIES, et al |
2:01-cv-02990 |
D.N.J. |
|
|
|
|